Oncology Live®

December 2012
Volume: 13
Issue: 12

November 2012
Volume: 13
Issue: 11

October 2012
Volume: 13
Issue: 10

September 2012
Volume: 13
Issue: 9

August 2012
Volume: 13
Issue: 8

July 2012
Volume: 13
Issue: 7

June 2012
Volume: 13
Issue: 6

May 2012
Volume: 13
Issue: 5

April 2012
Volume: 13
Issue: 4

March 2012
Volume: 13
Issue: 3

February 2012
Volume: 13
Issue: 2

January 2012
Volume: 13
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
2
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
3
May’s GI Monthly Rewind: A Landmark Approval in CCA, Expanded Access for Daraxonrasib, and More Key Pipeline Updates
4
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
5
